News

Pharmaceutical API Supplier for Turkey — WHO-GMP Export from India

Rate this post

Aarise Pharma is a WHO-GMP certified pharmaceutical API manufacturer and exporter based in Haridwar, India, supplying bulk active pharmaceutical ingredients and third-party manufactured dispersible tablet formulations to buyers in Turkey. Every shipment ships with an independent Certificate of Analysis (COA) and full regulatory documentation.

Pharmaceutical API Supplier for Turkey — Why Buyers Choose India

Turkey’s TİTCK bridges European and Middle Eastern/Central Asian regulatory expectations. The country has a growing local formulation industry that still depends heavily on imported bulk APIs, particularly for generics manufacturing. Aarise Pharma works directly with pharmaceutical manufacturers, contract formulators, and distributors in Turkey sourcing bulk APIs from India as an addition to, or replacement for, existing suppliers.

API & Formulation Categories Available for Turkey

Active Pharmaceutical Ingredients (APIs)

Bulk APIs across therapeutic categories including analgesics, antibiotics, antihistamines, and gastrointestinal formulations, manufactured to USP/BP/EP pharmacopoeial standards.

Dispersible Tablet Formulations

Contract-manufactured dispersible tablets, formulated and packaged to your specification — a core capability of the Haridwar facility.

Third-Party Manufacturing

Full third-party manufacturing for finished dosage forms, from formulation through packaging, for buyers in Turkey looking to private-label or scale an existing product line.

Quality Documentation We Provide

Every order from Aarise Pharma includes a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and WHO-GMP compliance documentation.

Shipping to Turkey

Standard delivery to Turkey is 10-16 business days by air freight, 30-40 days by sea. We handle export documentation and coordinate with your customs broker or local registration holder where the import process requires one.

Regulatory Information for Turkey

TİTCK (Türkiye İlaç ve Tıbbi Cihaz Kurumu) is the national authority governing pharmaceutical imports into Turkey. Turkey’s TİTCK bridges European and Middle Eastern/Central Asian regulatory expectations. The country has a growing local formulation industry that still depends heavily on imported bulk APIs, particularly for generics manufacturing.

Frequently Asked Questions

What pharmaceutical APIs does Aarise Pharma supply to Turkey?

Aarise Pharma manufactures and exports WHO-GMP certified active pharmaceutical ingredients, dispersible tablet formulations, and third-party manufactured finished products for buyers in Turkey, including generic drug manufacturers, contract formulators, and pharmaceutical distributors.

What documentation do you provide for TİTCK compliance?

Every shipment includes a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and Drug Master File (DMF) reference details, formatted to support your TİTCK registration or import filing.

How long does shipping to Turkey take?

Standard delivery to Turkey is 10-16 business days by air freight, 30-40 days by sea. We coordinate directly with your customs broker or local registration holder where the import process requires one.

Can Aarise Pharma manufacture a custom formulation for us?

Yes. Beyond bulk APIs, Aarise Pharma offers third-party contract manufacturing for dispersible tablets and other finished dosage forms, built to your specification and packaging requirements.

How do we request a quotation?

Send your required molecule, quantity, and target specification through our contact form, and our export team will respond with pricing, MOQ, and lead time within one business day.

Get Started — Request a Quotation for Turkey

Send us your required molecule, quantity, and specification, and our export team will respond with pricing, minimum order quantity, and lead time within one business day.

Other Export Markets

Aarise Pharma supplies pharmaceutical APIs to buyers across 18+ countries. See our other supplier guides:

View all export markets →